| identification of numerous hepatitis c virus genotypes in montreal, canada. | hepatitis c virus genotypes were determined for 358 viremic individuals in montreal, canada, by restriction endonuclease analysis of pcr products and phylogenetic analysis of core gene sequences. types 1, 2, and 3 occurred in 62.8, 14.2, and 13.7%, respectively; types 4 and 5 were found in 3.9 and 4.5%, respectively; and genotypes 6a and 7c and a novel genotype each occurred in 0.3%. types 4, 6, and 7 and the novel genotype were mostly from persons who had immigrated to canada. | 1996 | 8897188 |
| american society for virology-23rd annual meeting. vaccines and antiviral agents 10-14 july 2004, montreal canada. | | 2004 | 15470595 |
| use of the 5' noncoding region for genotyping hepatitis c virus. | | 1994 | 7906294 |
| hepatitis c virus genotypes in patients and blood donors--quebec. | | 1995 | 7670431 |
| hepatitis c virus incidence among young street-involved idus in relation to injection experience. | young injection drug users (idus) are at very high risk of hepatitis c virus (hcv) infection. using a time scale starting at first injection, we studied the period of hcv susceptibility after initiation into drug injection among street-involved idus. | 2009 | 19251382 |
| mode of transmission, rather than the hepatitis c virus, as a major determinant of poor interpersonal relationships in patients with chronic hepatitis c. | recent studies have demonstrated that patients with the hepatitis c virus (hcv) have significant neurocognitive impairment. | 2007 | 18080053 |
| use of sequence analysis of the ns5b region for routine genotyping of hepatitis c virus with reference to c/e1 and 5' untranslated region sequences. | nucleotide sequence analysis of the ns5b region was performed to identify genotypes of 8,479 hepatitis c virus (hcv) rna-positive patient samples collected in the canadian province of quebec. genotypes could be determined for 97.3% of patients. genotypes 1 to 6 were found in 59.4, 9.0, 25.7, 3.6, 0.6, and 1.8% of patients, respectively. two isolates did not classify within the six genotypes. the subtype 1 distribution was 76.7% 1a, 22.6% 1b, and 0.7% others, while the subtype 2 distribution was ... | 2007 | 17287328 |
| use of a novel washing method combining multiple density gradients and trypsin for removing human immunodeficiency virus-1 and hepatitis c virus from semen. | to determine the effectiveness of a novel treatment designed to remove human immunodeficiency virus (hiv) -1 and hepatitis c virus (hcv) from spiked semen and to evaluate sperm motility and viability after treatment. | 2005 | 16213856 |